Virginia Cannabis Decriminalization: Laws, Penalties, and Impact

Executive Summary

Virginia's cannabis decriminalization framework, enacted in July 2020 and expanded through adult-use legalization in July 2021, has fundamentally transformed the Commonwealth's approach to marijuana enforcement. Court data released in September 2026 confirms a massive 87% reduction in criminal cannabis prosecutions since decriminalization took effect, with simple possession cases dropping from approximately 28,600 annually in 2019 to fewer than 3,700 in 2025. Virginia became the first Southern state to legalize adult-use cannabis when Governor Ralph Northam signed House Bill 2312 into law on April 7, 2021, establishing a regulated market framework while immediately permitting possession of up to one ounce and home cultivation of up to four plants per household. The policy shift has eliminated tens of thousands of criminal cases annually, redirected law enforcement resources, and positioned Virginia as a regional outlier in cannabis policy—though the state's commercial market remains underdeveloped compared to mature programs in Colorado, California, and Massachusetts due to delayed retail licensing and restrictive zoning regulations.

Why This Matters

Virginia's decriminalization and legalization policies affect 8.6 million residents, eliminate criminal records that previously barred employment and housing, and represent a $698 million projected annual market by 2030. The prosecution data matters for multiple stakeholder groups. For the estimated 750,000 Virginia adults who use cannabis monthly according to the National Survey on Drug Use and Health, decriminalization eliminated the risk of criminal conviction, jail time, and permanent records that previously followed simple possession charges. Criminal justice reformers note that Black Virginians were arrested for cannabis possession at 3.5 times the rate of white residents despite similar usage rates, according to the American Civil Liberties Union's 2020 analysis of Virginia State Police data—a disparity that decriminalization directly addressed. For Virginia's court system, the reduction from 28,600 to 3,700 annual cannabis cases freed judicial resources equivalent to approximately 12,500 court hours annually, according to the Virginia Supreme Court's 2026 statistical report. Public defenders in Richmond, Norfolk, and Fairfax County reported caseload reductions of 15-18% following decriminalization, allowing more time for serious felony defense. The economic implications extend beyond criminal justice savings. Virginia's Cannabis Control Authority projected $300 million in annual tax revenue once the retail market matures, with funds designated for pre-kindergarten programs, substance abuse treatment, and communities disproportionately affected by prior enforcement. As of September 2026, only 47 retail dispensaries had opened statewide—far below the 400+ projected by industry analysts—creating a gap filled by unregulated sales and neighboring state purchases.

Background and History: Virginia's Path to Decriminalization

Virginia's journey from strict prohibition to adult-use legalization spanned five decades of incremental policy evolution, accelerating dramatically between 2018 and 2021.

Prohibition Era: 1970-2018

Virginia classified cannabis as a Schedule I controlled substance under the Virginia Drug Control Act (Title 18.2, Chapter 7) following the federal Controlled Substances Act of 1970. First-offense simple possession carried penalties of up to 30 days in jail and a $500 fine, with subsequent offenses classified as Class 1 misdemeanors punishable by up to 12 months incarceration and $2,500 fines. Between 1990 and 2018, Virginia courts processed an average of 24,000 marijuana possession cases annually, according to the Virginia State Crime Commission. The Commonwealth maintained one of the nation's strictest enforcement postures through the early 2000s. A 2010 analysis by the Virginia chapter of the National Organization for the Reform of Marijuana Laws found that Virginia arrested residents for cannabis at rates 40% higher than the national average, with particularly aggressive enforcement in Hampton Roads and Northern Virginia jurisdictions.

Medical Cannabis Authorization: 2015-2018

Virginia's first policy shift came on February 26, 2015, when Governor Terry McAuliffe signed Senate Bill 1235, establishing an affirmative defense for possession of cannabidiol oil or THC-A oil for treatment of intractable epilepsy. The law required a written certification from a licensed physician but created no legal supply mechanism, rendering it largely symbolic. The General Assembly expanded the program on March 14, 2018, through House Bill 1251 and Senate Bill 726, permitting five pharmaceutical processors to cultivate, process, and dispense cannabis products to registered patients with qualifying conditions. The Virginia Board of Pharmacy issued licenses to Columbia Care (Portsmouth), Dharma Pharmaceuticals (Bristol), gLeaf Medical (Richmond), Green Leaf Medical (Manassas), and Dalitso (Staunton). The first dispensary opened in March 2020, serving approximately 1,200 registered patients initially.

Decriminalization: July 1, 2020

The decriminalization breakthrough occurred during the 2020 legislative session. Delegate Steve Heretick introduced House Bill 972 on January 8, 2020, proposing to replace criminal penalties for first-offense simple possession with a $25 civil penalty. The bill passed the House of Delegates 64-34 on February 11, 2020, and the Senate 27-12 on March 5, 2020. Governor Northam signed the legislation on April 12, 2020, with an effective date of July 1, 2020. The law amended Virginia Code § 18.2-250.1 to make first-offense possession of up to one ounce a civil violation rather than a criminal misdemeanor. Subsequent offenses within three years remained Class 1 misdemeanors. The legislation also sealed prior simple possession convictions from public view and allowed expungement petitions. The immediate impact was dramatic. Virginia State Police reported 22,400 civil citations issued between July 2020 and June 2021, compared to 28,600 criminal charges filed in the 12 months prior—a 21% reduction in total enforcement actions alongside the elimination of criminal records.

Adult-Use Legalization: July 1, 2021

Building on decriminalization momentum and Democratic control of both legislative chambers, the General Assembly passed comprehensive adult-use legalization during the 2021 session. House Bill 2312 and Senate Bill 1406, introduced in January 2021, established a framework for legal possession, home cultivation, and commercial sales. The legislation passed the House 55-42 on February 5, 2021, and the Senate 23-15 on February 20, 2021, along largely partisan lines. Governor Northam signed the bill on April 7, 2021, with key provisions taking effect July 1, 2021—four years earlier than the original 2024 implementation timeline. The law amended Virginia Code § 4.1-600 et seq. to permit adults 21 and older to possess up to one ounce of cannabis and cultivate up to four plants per household (maximum two mature plants). It established the Virginia Cannabis Control Authority as the regulatory body, created a social equity licensing framework prioritizing applicants from communities with high prior arrest rates, and set a 21% excise tax on retail sales (later adjusted to 10% state excise tax plus local option taxes up to 3%). Critically, the legislation did not immediately authorize retail sales. The commercial market framework required additional regulatory development, with retail licensing applications opening in 2022 and the first adult-use dispensaries not opening until January 2024.

Regulatory Development: 2021-2024

The Cannabis Control Authority, established in November 2021 with a seven-member board appointed by the Governor and General Assembly, spent 18 months developing comprehensive regulations. The agency published proposed rules in the Virginia Register on March 14, 2022, covering cultivation, processing, testing, retail operations, and social equity provisions. The regulatory framework established five license types: cultivation (Tier I-III based on canopy size), manufacturing/processing, testing laboratories, retail dispensaries, and vertically integrated operations. Social equity applicants—defined as individuals from zip codes with cannabis arrest rates 150% above the state average or household incomes below 80% of area median—received application fee waivers and priority review. The first retail application window opened September 1, 2022, and closed November 30, 2022. The Authority received 723 applications for 450 available licenses. License awards began in May 2023, with the first adult-use retail sales occurring on January 11, 2024, at a Richmond dispensary operated by Beyond-Hello Virginia.

Post-Legalization Adjustments: 2024-2026

The General Assembly made several technical corrections during the 2024 and 2025 sessions. House Bill 698 (2024) clarified that landlords could not prohibit home cultivation in rental properties unless specified in leases signed after July 1, 2021. Senate Bill 891 (2025) expanded expungement eligibility to include distribution charges under two ounces and reduced the excise tax from 21% to 10% to improve legal market competitiveness against unregulated sales. As of September 2026, Virginia had issued 312 retail licenses, though only 47 dispensaries had opened due to local zoning restrictions, capital access challenges, and supply chain bottlenecks. The slow retail rollout meant that legal home cultivation and gifting remained the primary access methods for most Virginia consumers, with an estimated 60% of cannabis obtained outside licensed channels according to a July 2026 Virginia Commonwealth University survey.

Key Players

Virginia Cannabis Control Authority

The Cannabis Control Authority serves as the primary regulatory body, responsible for licensing, compliance, and market oversight. Executive Director Aaron Bowles, appointed in December 2021, oversees a staff of 87 employees and a $14.2 million annual budget funded through application fees and license renewals. The Authority operates under the Virginia Alcoholic Beverage Control Authority's administrative umbrella but maintains independent decision-making authority for cannabis policy.

Governor Glenn Youngkin

Republican Governor Glenn Youngkin, who took office in January 2022, inherited the legalization framework established under his predecessor. Youngkin opposed adult-use legalization during his 2021 campaign but declined to pursue repeal legislation, instead focusing on tightening regulations around public consumption and impaired driving. His administration proposed unsuccessful amendments in 2023 to delay retail licensing and reduce home cultivation limits from four to two plants.

Virginia NORML

The Virginia chapter of the National Organization for the Reform of Marijuana Laws, led by Executive Director Jenn Michelle Pedini, played a central advocacy role throughout decriminalization and legalization campaigns. The organization coordinated grassroots lobbying, provided legislative testimony, and mobilized constituent contact with General Assembly members. Virginia NORML continues to advocate for expanded expungement, reduced local zoning restrictions, and social equity program improvements.

Justice Forward Virginia

This coalition of criminal justice reform organizations, including the ACLU of Virginia, Virginia Organizing, and the Legal Aid Justice Center, focused advocacy on racial equity dimensions of cannabis policy. The coalition's 2019 report documenting racial disparities in enforcement provided key data cited during legislative debates. Justice Forward Virginia currently monitors expungement implementation and advocates for reinvestment of tax revenue in affected communities.

Virginia Association of Chiefs of Police

Law enforcement leadership initially opposed both decriminalization and legalization, with the Virginia Association of Chiefs of Police testifying against House Bill 972 in February 2020, citing concerns about impaired driving detection and youth access. The organization has since shifted to a neutral position, focusing on securing funding for drug recognition expert training and roadside testing technology. Chief Paul Neudigate of the Virginia Beach Police Department testified in January 2025 that decriminalization had not produced the public safety concerns initially anticipated.

Medical Cannabis Operators

The five original pharmaceutical processors—Columbia Care, Dharma Pharmaceuticals, gLeaf Medical, Green Leaf Medical, and Dalitso—received priority consideration for adult-use licenses based on their existing operations. Columbia Care (acquired by Cresco Labs in 2023) operates the largest cultivation facility in Portsmouth with 150,000 square feet of canopy. These vertically integrated operators currently supply approximately 70% of legal retail inventory statewide.

Legal and Regulatory Framework

Virginia's cannabis legal structure rests on amendments to Title 4.1 (Alcoholic Beverage and Cannabis Control) and Title 18.2 (Crimes and Offenses) of the Virginia Code, creating a regulated adult-use market while maintaining criminal penalties for unlicensed sales and public consumption. Virginia Code § 4.1-600 establishes that adults 21 and older may lawfully possess up to one ounce of cannabis. Possession of more than one ounce but less than one pound constitutes a Class 3 misdemeanor punishable by a fine up to $500. Possession exceeding one pound remains a felony under § 18.2-248.1, carrying penalties of one to ten years imprisonment. Section 4.1-600.1 permits home cultivation of up to four cannabis plants per household, with a maximum of two mature flowering plants. Plants must be cultivated in the primary residence, tagged with the cultivator's name and driver's license number, and kept in an area not visible from public view and inaccessible to persons under 21. Violations constitute Class 3 misdemeanors for first offenses. Virginia Code § 4.1-601 prohibits public consumption, defined as use in any public place or in a motor vehicle. Violations carry civil penalties of $25 for first offenses and Class 4 misdemeanor charges for subsequent violations. Localities may impose additional restrictions on consumption in public parks and outdoor areas. The regulatory framework under § 4.1-1600 et seq. establishes licensing requirements for commercial operations. Cultivation licenses require background checks, financial disclosures, and facility inspections. Tier I licenses (up to 2,500 square feet canopy) cost $2,000 annually; Tier II (2,501-10,000 square feet) cost $10,000; Tier III (over 10,000 square feet) cost $60,000. Retail dispensary licenses cost $5,000 annually plus $25,000 application fees, with 50% fee reductions for social equity applicants. Section 4.1-1603 establishes social equity criteria, granting priority review and technical assistance to applicants who are Virginia residents, have household incomes below 80% of area median, and reside in or plan to operate in zip codes with historical cannabis arrest rates exceeding 150% of the state average. The Authority designated 47 zip codes across Richmond, Norfolk, Petersburg, and rural Southside Virginia as social equity zones. Testing requirements under § 4.1-1604 mandate independent laboratory analysis for potency, pesticides, heavy metals, microbials, and mycotoxins before retail sale. Products must contain less than 0.3% delta-9 THC per dry weight for hemp-derived products or be sold exclusively through licensed dispensaries for cannabis products exceeding that threshold. Taxation occurs at multiple levels. Virginia Code § 4.1-1701 imposes a 10% excise tax on retail sales, collected at the point of sale. Localities may impose additional taxes up to 3% through ordinance. Standard sales tax of 5.3% also applies, creating a total tax burden of 15.3-18.3% depending on locality. Driving under the influence provisions under § 18.2-266 prohibit operation of a motor vehicle while impaired by cannabis, with per se limits established at 3 nanograms of delta-9 THC per milliliter of blood. First-offense DUI carries penalties identical to alcohol DUI: up to 12 months in jail, $250-2,500 fines, and 12-month license suspension. The Virginia Department of Forensic Science operates blood testing facilities in Richmond, Roanoke, and Manassas for THC quantification. Expungement provisions under § 19.2-392.2:1 permit automatic sealing of simple possession convictions occurring before July 1, 2021. The Virginia State Police sealed approximately 122,000 records between July 2021 and December 2025. Individuals may petition for expungement of distribution charges involving less than two ounces, subject to judicial discretion.

State-by-State Regional Context

Virginia's legalization positioned the Commonwealth as a regional outlier in the Southeast, where neighboring states maintain prohibition or limited medical-only programs.

Virginia

Adult-use legal since July 1, 2021. Possession limit: one ounce. Home cultivation: four plants per household. Retail sales operational since January 2024 with 47 dispensaries open as of September 2026. Social equity licensing prioritizes applicants from high-arrest zip codes. Expungement available for prior simple possession convictions. Tax rate: 10% excise plus 5.3% sales tax plus up to 3% local option tax.

Maryland

Adult-use legalization approved by voters in November 2022 referendum, with retail sales beginning July 1, 2023. Possession limit: 1.5 ounces. Home cultivation: two plants per person, four per household. Maryland issued 111 retail licenses by September 2026, creating more robust market access than Virginia despite later legalization. Tax rate: 9% excise tax. Maryland's proximity creates cross-border shopping for Northern Virginia residents.

North Carolina

Medical cannabis only, with limited low-THC CBD program established in 2014. House Bill 617, which would have legalized medical cannabis, passed the North Carolina House in June 2023 but stalled in the Senate. Simple possession remains a criminal misdemeanor punishable by up to 30 days jail and $200 fine. Decriminalization bills failed in 2024 and 2025 sessions.

West Virginia

Medical cannabis legal since 2017, with dispensaries opening in 2021. Adult-use remains prohibited. Possession of any amount constitutes a misdemeanor punishable by up to six months jail and $1,000 fine. The West Virginia Legislature rejected decriminalization proposals in 2024 and 2026. Medical program serves approximately 12,000 registered patients as of September 2026.

Tennessee

Prohibition state with no medical program beyond limited low-THC CBD oil for intractable seizures. Simple possession remains a Class A misdemeanor punishable by up to 11 months, 29 days in jail and $2,500 fine. Tennessee maintains some of the nation's strictest cannabis penalties, with second-offense possession classified as a felony. Decriminalization bills have not advanced past committee since 2019.

Kentucky

Medical cannabis legalized in March 2023 through Senate Bill 47, with dispensaries scheduled to open in January 2025. Adult-use possession remains illegal. Kentucky decriminalized possession of up to eight ounces in Louisville and Lexington through local ordinances, but state law still classifies possession as a Class B misdemeanor punishable by up to 45 days jail and $250 fine.

District of Columbia

Adult-use possession and home cultivation legal since 2015 through Initiative 71. Possession limit: two ounces. Home cultivation: six plants per person, 12 per household. Retail sales remain prohibited due to Congressional budget riders blocking implementation of taxation and regulation framework. Gifting model dominates, with businesses selling non-cannabis products and "gifting" cannabis. Medical dispensaries serve registered patients separately.

Market and Business Implications

Virginia's cannabis market generated an estimated $127 million in legal retail sales during the first 20 months of adult-use operations (January 2024-August 2026), far below initial projections of $400-500 million annually, while the unregulated market continues to account for 60-65% of total consumption. The slow retail rollout created a supply-constrained market with limited geographic access. As of September 2026, 47 operational dispensaries served 8.6 million residents—a ratio of one dispensary per 183,000 people, compared to one per 8,000 in Colorado and one per 12,000 in Massachusetts. Richmond (population 1.3 million metro) had seven dispensaries; Hampton Roads (1.8 million) had nine; Northern Virginia (3.1 million) had 18. Southside Virginia and the Shenandoah Valley remained largely unserved. Wholesale pricing reflected supply constraints. Cultivators received an average of $1,800-2,200 per pound for premium flower in August 2026, according to Virginia Cannabis Business Association data—substantially higher than the $800-1,200 per pound prevailing in mature markets. Retail prices averaged $45-55 per eighth ounce ($320-390 per ounce), compared to $25-35 per eighth in Michigan and Oregon. The high tax burden compounded competitiveness challenges. The combined 15.3-18.3% tax rate (10% excise, 5.3% sales, 0-3% local) made Virginia one of the highest-taxed markets nationally, exceeded only by Washington (37%) and Illinois (up to 41% depending on potency). Industry representatives testified before the General Assembly in January 2026 that the tax structure drove consumers to unregulated sources and neighboring Maryland, where the 9% excise tax created lower total prices. Multi-state operators established dominant market positions. Cresco Labs (through its Columbia Care acquisition), Curaleaf, and Green Thumb Industries collectively controlled approximately 55% of licensed retail capacity as of September 2026. These vertically integrated operators leveraged existing cultivation and processing infrastructure from medical operations to supply adult-use inventory, creating barriers to entry for smaller cultivators who struggled to secure distribution agreements. Social equity licensing produced mixed results. The Cannabis Control Authority awarded 89 licenses (28% of total) to social equity applicants between May 2023 and August 2026. However, only 11 social equity licensees had opened operational businesses by September 2026—a 12% activation rate compared to 18% for standard applicants. Capital access remained the primary barrier, with social equity applicants reporting difficulty securing loans from traditional banks due to federal prohibition under the Controlled Substances Act and Virginia's lack of a state-chartered cannabis banking system. Employment in the legal cannabis sector reached approximately 2,400 full-time equivalent positions by August 2026, according to Virginia Employment Commission data—below the 8,000-10,000 jobs projected by legalization advocates. Cultivation facilities employed an average of 35-40 workers; retail dispensaries averaged 8-12 employees. Median wages for budtenders ranged from $15-18 per hour; cultivation technicians earned $17-22 per hour; extraction technicians commanded $22-28 per hour. Ancillary businesses—including testing laboratories, security firms, compliance consultants, and packaging suppliers—generated an additional estimated 800-1,000 jobs. Virginia had six licensed testing laboratories as of September 2026, charging $400-600 per batch for comprehensive compliance panels. Testing requirements created bottlenecks, with laboratories reporting 10-14 day turnaround times during peak periods. Real estate impacts varied by locality. Northern Virginia jurisdictions including Arlington County, Alexandria, and Fairfax County imposed restrictive zoning that limited dispensaries to industrial areas, reducing retail viability. Richmond adopted more permissive regulations allowing dispensaries in commercial corridors, resulting in higher license activation rates. Retail rents for dispensary-suitable properties (requiring vault storage and security systems) ranged from $35-50 per square foot annually in urban markets. The medical cannabis program, which served approximately 47,000 registered patients as of August 2026, continued operating separately from adult-use retail. Medical patients paid no excise tax and accessed higher-potency products (up to 1,000mg THC edibles versus 100mg adult-use limits). Medical sales totaled an estimated $89 million in 2025, declining from $112 million in 2023 as some patients shifted to lower-cost adult-use channels.

What Experts Say

Policy analysts, law enforcement officials, and industry stakeholders describe Virginia's decriminalization as successful in reducing criminal justice burdens while noting that the commercial market remains underdeveloped compared to other legal states. Jenn Michelle Pedini, executive director of Virginia NORML, said in a September 2026 statement that the court data demonstrating an 87% reduction in criminal prosecutions validated the policy shift. According to Pedini, the elimination of tens of thousands of criminal cases annually represented "the most significant criminal justice reform Virginia has enacted in a generation," particularly for communities that experienced disproportionate enforcement under prohibition. The ACLU of Virginia's 2026 policy brief, authored by Criminal Justice Reform Director Ashena Khandelwal, found that racial disparities in cannabis enforcement declined substantially following decriminalization. According to the analysis, the ratio of Black-to-white enforcement actions dropped from 3.5:1 in 2019 to 1.8:1 in 2025, though disparities persisted in charges for public consumption and distribution. Chief Paul Neudigate of the Virginia Beach Police Department testified before the General Assembly's Public Safety Committee in January 2025 that decriminalization had not produced anticipated increases in impaired driving or youth access. According to Neudigate, traffic fatalities involving THC-positive drivers remained statistically unchanged between 2019 (47 fatalities) and 2024 (51 fatalities), within normal year-to-year variation. The Virginia Association of Chiefs of Police shifted from opposition to a neutral position in 2024, focusing advocacy on securing funding for drug recognition expert training rather than seeking policy reversal. Dr. Michelle Peace, director of the Virginia Commonwealth University Forensic Science Program, said in an August 2026 interview that blood THC testing presented challenges for impairment determination. According to Peace, the 3 nanogram per se limit established in Virginia Code § 18.2-266 lacked strong scientific correlation with actual impairment, as THC remains detectable in blood for hours after psychoactive effects subside. Peace advocates for standardized field sobriety protocols rather than reliance on per se limits. Aaron Bowles, executive director of the Cannabis Control Authority, said in a July 2026 stakeholder meeting that regulatory development required balancing market access with public health protections. According to Bowles, the Authority prioritized thorough vetting of license applicants and robust testing requirements over rapid market expansion, contributing to the slower-than-projected retail rollout. Bowles projected that 150-200 dispensaries would be operational by December 2027 as local zoning barriers declined and capital access improved. Michael Correia, director of government relations for the National Cannabis Industry Association, said in testimony before the Virginia Senate Finance Committee in February 2026 that the state's tax structure undermined legal market competitiveness. According to Correia, the combined 15.3-18.3% tax burden, coupled with federal 280E tax treatment that prohibits standard business deductions for cannabis operators, created a 45-50% effective tax rate that made legal products 30-40% more expensive than unregulated alternatives. Dr. Jill McCabe, a health economist at the University of Virginia who studies cannabis markets, published research in the Journal of Drug Policy Analysis in June 2026 finding that Virginia's limited retail access drove continued unregulated market activity. According to McCabe's analysis of consumer survey data, 62% of Virginia cannabis users reported obtaining products through home cultivation, gifting, or unregulated sources as of early 2026, compared to 25-30% in mature markets with robust retail networks. Dale Gieringer, director of California NORML and a longtime cannabis policy analyst, said in a September 2026 interview that Virginia's experience illustrated the importance of coordinating legalization with rapid retail licensing. According to Gieringer, California's similar delay between legalization (January 2018) and widespread retail availability (2019-2020) allowed unregulated markets to entrench, creating long-term competitiveness challenges that persisted years later.

What's Next

Virginia's cannabis policy faces several decision points in 2027-2028, including potential tax restructuring, expanded expungement, and local zoning preemption, while the federal rescheduling process could fundamentally alter the regulatory landscape. The General Assembly's 2027 session, convening in January, will consider Senate Bill 412, introduced by Senator Ghazala Hashmi, which would reduce the state excise tax from 10% to 6% and prohibit localities from imposing additional taxes exceeding 2%. The bill aims to improve legal market price competitiveness and has bipartisan support from fiscal conservatives concerned about unregulated market tax revenue losses. The Senate Finance Committee is scheduled to hold hearings in February 2027. Expungement expansion remains a priority for criminal justice reform advocates. House Bill 1847, pre-filed for the 2027 session by Delegate Don Scott, would establish automatic expungement for all cannabis-related convictions involving conduct now legal under current law, including distribution charges under one ounce and cultivation offenses. The legislation would eliminate the current petition requirement and expand eligibility beyond simple possession. The bill faces opposition from some prosecutors who argue that distribution charges involved commercial activity distinct from personal use. Local zoning preemption proposals will be debated in 2027. Delegate Schuyler VanValkenburg plans to introduce legislation prohibiting localities from banning cannabis businesses outright, requiring that zoning ordinances permit dispensaries in at least 25% of commercially zoned areas. The proposal responds to restrictive zoning in Fairfax County, Loudoun County, and Virginia Beach that has limited retail access. The Virginia Association of Counties opposes preemption as an infringement on local land-use authority. The Cannabis Control Authority will open a second retail license application window in March 2027, with 200 additional licenses available. The Authority plans to prioritize underserved regions including Southside Virginia, the Shenandoah Valley, and Southwest Virginia. Social equity applicants will receive 40% of available licenses, up from 28% in the first round, with enhanced technical assistance and a $5 million grant program funded through license fees. Federal rescheduling represents the most significant external factor. The Drug Enforcement Administration's proposed rule to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act, published in the Federal Register on May 21, 2024, remains under review following a public comment period that closed in July 2024. If finalized, rescheduling would eliminate Internal Revenue Code § 280E restrictions that currently prohibit cannabis businesses from deducting ordinary business expenses, potentially reducing effective tax rates by 25-35 percentage points and dramatically improving legal market economics. The U.S. Department of Justice's ongoing review of cannabis banking restrictions could also impact Virginia operators. The SAFER Banking Act, which would permit federally insured banks to serve state-legal cannabis businesses without risk of federal prosecution or regulatory sanctions, passed the House of Representatives in September 2023 but stalled in the Senate. Renewed consideration is expected in the 118th Congress (2027-2028). Banking access would significantly improve capital availability for social equity applicants and smaller operators. Virginia's medical cannabis program faces integration questions. The Cannabis Control Authority is studying whether to maintain separate medical and adult-use markets or transition to a unified system with medical patients receiving tax exemptions and higher purchase limits within a single retail framework. A decision is expected by June 2027, with any structural changes implemented in 2028. Youth prevention and education programs will expand in 2027-2028 as tax revenue grows. The Virginia Department of Health received $8.2 million in cannabis tax allocations for fiscal year 2026, funding school-based prevention curricula and public awareness campaigns. The department plans to launch a statewide media campaign in spring 2027 targeting parents and adolescents, modeled on Colorado's "Good to Know" program. Interstate commerce remains prohibited under federal law, but Virginia has joined a multi-state working group exploring regional reciprocity agreements for medical cannabis patients and potential frameworks for interstate commerce if federal prohibition ends. The working group, which includes Maryland, New Jersey, and Connecticut, is developing model legislation for consideration in 2028.

Further Reading

• Virginia Code § 4.1-600 et seq. (Cannabis Control Act) - https://law.lis.virginia.gov/vacode/title4.1/chapter6/
• Virginia Cannabis Control Authority Official Website - https://www.cannabis.virginia.gov/
• Virginia State Crime Commission, "Cannabis Decriminalization Impact Study" (2025) - https://rga.lis.virginia.gov/Published/2025/RD234
• ACLU of Virginia, "A Tale of Two Virginias: Racial Disparities in Marijuana Enforcement" (2020) - https://acluva.org/marijuana-enforcement-report
• Virginia NORML Legislative Tracking - https://www.vanorml.org/legislation
• National Conference of State Legislatures, "State Medical Cannabis Laws" - https://www.ncsl.org/health/state-medical-cannabis-laws
• Drug Enforcement Administration, "Schedules of Controlled Substances: Rescheduling of Marijuana" [Proposed Rule], 89 Fed. Reg. 44,597 (May 21, 2024) - https://www.federalregister.gov/documents/2024/05/21/2024-11137/
• Virginia Employment Commission, "Cannabis Industry Employment Data" (2026) - https://www.vec.virginia.gov/industry-data
• Virginia Department of Health, "Cannabis Public Health Impact Report" (2026) - https://www.vdh.virginia.gov/cannabis/
• Journal of Drug Policy Analysis, McCabe et al., "Retail Access and Market